In the latest episode of Impetus Digital's Fireside Chat, Natalie Yeadon, Co-Founder and CEO of Impetus Digital sits down with Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders. They explore a range of topics related to rare disease treatment and advocacy, including how to best involve patients in all aspects of the drug lifecycle and innovative approaches to drug access and financing.
Schedule a meeting with Natalie Yeadon: https://www.meetwithnatalie.com
Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/
Impetus Digital Website: https://www.impetusdigital.com/
Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/
Impetus Digital Twitter: https://twitter.com/Impetusadboards
Impetus YouTube: https://www.youtube.com/Impetushealthcare
Durhane Wong-Rieger: https://www.linkedin.com/in/durhane-wong-rieger-5851b39/
Canadian Organization for Rare Disorders: http://www.raredisorders.ca/
In the latest episode of Impetus Digital's Fireside Chat, Natalie Yeadon, Co-Founder and CEO of Impetus Digital sits down with Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders. They explore a range of topics related to rare disease treatment and advocacy, including how to best involve patients in all aspects of the drug lifecycle and innovative approaches to drug access and financing.
Schedule a meeting with Natalie Yeadon: https://www.meetwithnatalie.com
Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/
Impetus Digital Website: https://www.impetusdigital.com/
Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/
Impetus Digital Twitter: https://twitter.com/Impetusadboards
Impetus YouTube: https://www.youtube.com/Impetushealthcare
Durhane Wong-Rieger: https://www.linkedin.com/in/durhane-wong-rieger-5851b39/
Canadian Organization for Rare Disorders: http://www.raredisorders.ca/